Barely Significant
← all excerpts

Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis.

Biomedicines · 2022 · PMC9405513 · PMID 36009370

Europe PMCDOI
1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

a mild trendp = 0.057so close (0.05 < p ≤ 0.1)
When we compared individuals who maintained the regimen with those who continued it ( Table 1 ), we detected a significant difference in HCV antibody positivity prevalence, length of HIV infection, neurological and psychiatric disorders prevalence, and polypharmacy; a mild trend was also observed for the type of regimen before switching to BIC/FTC/TAF ( p = 0.057).

also in 257 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.